Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutathione‐Bioimprinted Nanoparticles Targeting of N6‐methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells
Kunxia Cao, Yangyang Du, Xin Bao, et al.
Small (2022) Vol. 18, Iss. 13
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 576
N6-methyladenosine-mediated gene regulation and therapeutic implications
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 60
Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade
Ying Xue, Fujia Lu, Zhenzhen Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 55
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy
Qing Li, Rui Su, Xin Bao, et al.
Acta Biomaterialia (2022) Vol. 144, pp. 109-120
Closed Access | Times Cited: 65
A Bimetallic Metal–Organic‐Framework‐Based Biomimetic Nanoplatform Enhances Anti‐Leukemia Immunity via Synchronizing DNA Demethylation and RNA Hypermethylation
Yue Song, Lingxiao Zhang, Yiqiao Wang, et al.
Advanced Materials (2023) Vol. 35, Iss. 16
Closed Access | Times Cited: 28
Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification
Hongliang Shen, Zixiang Geng, Xiaoli Nie, et al.
Journal of Cancer (2023) Vol. 14, Iss. 3, pp. 367-378
Open Access | Times Cited: 27
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
Xianyong Zhou, Chen Li, Tong Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
Jing Cai, Xiaoding Xu, Phei Er Saw
Science China Life Sciences (2023) Vol. 67, Iss. 1, pp. 19-40
Closed Access | Times Cited: 22
Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy
Li Yu, Ke Huang, Yixiang Liao, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 13
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 8
Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving N6-Methyladenosine-Mediated Second Near-Infrared Photothermal Immunotherapy
Jianhua Liu, Yue Song, Yiqiao Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 36, pp. 40612-40623
Closed Access | Times Cited: 32
Gold Nanorod–mesoporous silica core shell nanocomposites for NIR-II photothermal ablation and dual PD-L1/VEGF blockade therapy in hepatocellular carcinoma
Xinlun Dai, Xin Li, Yangyang Du, et al.
Chemical Engineering Journal (2023) Vol. 459, pp. 141426-141426
Closed Access | Times Cited: 21
Nanomedicine-mediated regulated cell death in cancer immunotherapy
Yue Sun, Ting Lian, Qichao Huang, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 174-194
Closed Access | Times Cited: 20
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Weiwei Liu, Zhongyuan Zhang, Fei Wang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Emerging drugs targeting cellular redox homeostasis to eliminate acute myeloid leukemia stem cells
Rafaela G.A. Costa, Suellen L.R. Silva, Ingrid R. S. B. Dias, et al.
Redox Biology (2023) Vol. 62, pp. 102692-102692
Open Access | Times Cited: 14
N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications
Liming Wang, Yuanxin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114846-114846
Open Access | Times Cited: 13
Ultrasound-Triggered O2 Bombs: Perfluorobromooctane-Loaded Defect-Rich Metal-Organic framework for enhanced Sono-Immunotherapy
Yilin Yang, Ning Wang, Zhihua Wang, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145764-145764
Closed Access | Times Cited: 13
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
Yu Rong, Yinhui Hang, Hsiang‐i Tsai, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 5
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
The role of m6A-mediated PD-1/PD-L1 in antitumor immunity
Li Liu, Long Liang, Hui Li, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115460-115460
Closed Access | Times Cited: 11
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal
Hongqiao Cai, Xiaocheng Li, Yahui Liu, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 152175-152175
Closed Access | Times Cited: 4
Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression
Qingqing Wei, Changning Xue, Mengna Li, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 6, pp. 1119-1132
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top